ESC 365 - BAROSTIM therapy in patients with HFrEF: A patient level meta-analysis of randomized trials

HFA Premium Access

BAROSTIM therapy in patients with HFrEF: A patient level meta-analysis of randomized trials

Session: Late-Breaking Trials 3

Topic: Devices for Autonomic Modulation

Speaker: Professor A. Stewart Coats (Sydney, AU)

Event: Heart Failure 2021

Congress Presentation

About the speaker

Professor Andrew Stewart Coats

Heart Research Institute, Sydney (Australia)

111 presentations

21 followers

2 more presentations in this session

Effect on Maximal Functional Capacity of Betablockers Withdrawal in Heart Failure with Preserved Ejection Fraction and Chronotropic Incompetence: Preserve-HR trial

Speaker: Doctor J. Nunez Villota (Valencia, ES)

Effect of Dapagliflozin vs Placebo on Symptoms and Six-Minute Walk Distance in Patients with Heart Failure

Speaker: Professor J. McMurray (Glasgow, GB)

Access the full session

Late-Breaking Trials 3

Speakers: Professor A. Stewart Coats, Doctor J. Nunez Villota, Professor J. McMurray

About the event

Heart Failure 2021

29 June - 1 July 2021

Sessions Presentations

Congress

ESC 365 is supported by